Camber Pharmaceuticals rolls out generic Invega Paliperidone Extended-Release Tablets is an atypical antipsychotic agent indicated for the treatment of schizophrenia and schizoaffective disorder. ScriptAbility integrates with McKesson’s EnterpriseRxThe integration enables EnterpriseRx pharmacy clients to help ensure medication adherence and safety by providing accessible prescription labels. Tandem Diabetes Care debuts Tandem Mobi Tandem Mobi aims to help individuals living with diabetes to experience the benefits of Control-IQ technology, the company said. NACDS regional conference’s 2nd day focuses on health, wellness trends Panelists discussed health and wellness innovation, the Nourish My Health public education campaign and pharmacy’s role in value-based care, among other topics. Pharmacy orgs urge Congress to finish bipartisan work on PBM reforms in Medicare, Medicaid Several essential reforms have advanced in the 118th Congress, such as Medicaid managed care pharmacy payment reform and a ban on spread pricing. CHPA to hold 2024 Self-Care Leadership Summit in March Attendees will have the opportunity to hear from former FDA Commissioner Dr. Scott Gottlieb and others. Teva intends to divest API business The intended divestiture is expected to play an important role in Teva's “Pivot to Growth” strategy. NACDS regional chain conference highlights policy battles, accelerated innovation The 2024 Conference—“Within Reach”—takes place Feb. 11 to 13 in Bonita Springs, Fla., and is the kick-off to NACDS meetings and conferences this year. Former House Speaker Paul Ryan to address NACDS-PAC event Ryan will speak at the Chain Members and Political Action Committee Breakfast. Lupin receives FDA nod for 2 generics, launches generic Nascobal Lupin obtained approval for generic BromSite and generic Multaq and launched generic Nascobal. First Previous 64 65 66 67 68 Next Last